Article Information
PubMed
Print ISSN
Online ISSN
History
- Received August 21, 2007
- Accepted October 31, 2007
- Published online January 24, 2008.
Article Versions
- Earlier version (November 5, 2007 - 10:27).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Donglu Zhang,
- Nirmala Raghavan,
- Shiang-Yuan Chen,
- Haiying Zhang,
- Mimi Quan,
- Lloyd Lecureux,
- Laura M. Patrone,
- Patrick Y. S. Lam,
- Samuel J. Bonacorsi,
- Robert M. Knabb,
- Gary L. Skiles1 and
- Kan He
- Pharmaceutical Candidate Optimization (D.Z., N.R., H.Z., L.L., G.L.S., K.H.), Radiochemistry (S.-Y.C., S.J.B.), Discovery Chemistry (M.Q., P.Y.S.L.), Drug Safety Evaluation (L.M.P.), and Discovery Biology (R.M.K.), Bristol-Myers Squibb Research and Development, Princeton, New Jersey
- Address correspondence to:
Dr. Donglu Zhang, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, NJ 08543. E-mail: donglu.zhang{at}bms.com
Statistics from Altmetric.com
Article usage
In this issue
Reductive Isoxazole Ring Opening of the Anticoagulant Razaxaban Is the Major Metabolic Clearance Pathway in Rats and Dogs
